Stocks · News reference
Barclays analyst Tim Long maintains Fabrinet (NYSE:FN) with a Overweight and raises the price target from $702 to $739.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Coherent Corp. is projected to deliver strong fiscal 2027 revenue growth of 50.1% and earnings growth of 67.2%, driven by AI-optics demand. However, the stock trades at a premium 26.5X forward earnings with rising capital expenditures and weakening operating cash flow, creating execution risks. While earnings estimates are rising favorably, valuation and cash-flow pressures present concerns for investors.
There is no shortage of investment managers willing to tell you they are fundamental investors doing deep research in search of mispriced securities. The phrase has become so common that it has almost lost its
U.S. stocks closed lower on Tuesday amid inflation and oil concerns. The Fear and Greed Index moved to Neutral zone at 54.3.
Fabrinet's margin miss triggered a brutal selloff across the stock market today, while $91 Brent kept equities under pressure